Merck (NYSE:MRK) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted priority review for its request ...

Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% ...

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

Priority Cycles' Current Plus e-commuter bike delivers good range and power, plus features a low-maintenance Gates belt-drive ...

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...

The FDA approval of Vimkunya has given the chikungunya vaccine’s owner, Bavarian Nordic, an extra financial windfall. | The ...

The US Food and Drug Administration (FDA) has granted priority review to AstraZeneca's supplemental biologics licence application (sBLA) for Imfinzi (durvalumab), a human monoclonal antibody, for ...

Priority review vouchers. The program is called the Priority Review Voucher Program for Neglected Diseases. When it was created, it covered specific diseases — among them, leprosy, malaria, and ...

Priority E-Coast review: The competition. Priced at $1,999, the Priority E-Coast costs the same as our favorite ebike overall, Rad Power RadCity 5 Plus.

Priority review vouchers are one tool in the policy incentives toolbox, and have proven to be of interest to developers and stakeholders as a means of encouraging innovation in areas of unmet ...